Annual Operating Expenses
$173.61 M
-$4.37 M-2.45%
31 December 2023
Summary:
Cytokinetics Incorporated annual total operating expenses is currently $173.61 million, with the most recent change of -$4.37 million (-2.45%) on 31 December 2023. During the last 3 years, it has risen by +$120.79 million (+228.69%). CYTK annual operating expenses is now -2.45% below its all-time high of $177.98 million, reached on 31 December 2022.CYTK Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$56.65 M
+$5.83 M+11.47%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly total operating expenses is currently $56.65 million, with the most recent change of +$5.83 million (+11.47%) on 30 September 2024. Over the past year, it has increased by +$16.54 million (+41.24%). CYTK quarterly operating expenses is now at all-time high.CYTK Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.5% | +41.2% |
| 3 y3 years | +228.7% | +116.2% |
| 5 y5 years | +455.0% | +480.9% |
CYTK Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2.5% | +228.7% | at high | +116.2% |
| 5 y | 5 years | -2.5% | +455.0% | at high | +480.9% |
| alltime | all time | -2.5% | +1296.8% | at high | +320.3% |
Cytokinetics Incorporated Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $56.65 M(+11.5%) |
| June 2024 | - | $50.82 M(+11.7%) |
| Mar 2024 | - | $45.50 M(+3.1%) |
| Dec 2023 | $173.61 M(-2.5%) | $44.11 M(+10.0%) |
| Sept 2023 | - | $40.11 M(+1.0%) |
| June 2023 | - | $39.72 M(-20.0%) |
| Mar 2023 | - | $49.66 M(-8.0%) |
| Dec 2022 | $177.98 M(+83.9%) | $53.97 M(+11.9%) |
| Sept 2022 | - | $48.22 M(+12.9%) |
| June 2022 | - | $42.72 M(+29.2%) |
| Mar 2022 | - | $33.07 M(-2.2%) |
| Dec 2021 | $96.80 M(+83.3%) | $33.81 M(+29.0%) |
| Sept 2021 | - | $26.20 M(+23.6%) |
| June 2021 | - | $21.20 M(+35.9%) |
| Mar 2021 | - | $15.60 M(+12.2%) |
| Dec 2020 | $52.82 M(+33.4%) | $13.91 M(+13.1%) |
| Sept 2020 | - | $12.30 M(-13.1%) |
| June 2020 | - | $14.16 M(+13.8%) |
| Mar 2020 | - | $12.45 M(+17.6%) |
| Dec 2019 | $39.61 M(+26.6%) | $10.58 M(+8.5%) |
| Sept 2019 | - | $9.75 M(-0.8%) |
| June 2019 | - | $9.84 M(+4.2%) |
| Mar 2019 | - | $9.44 M(+24.9%) |
| Dec 2018 | $31.28 M(-14.2%) | $7.56 M(+5.5%) |
| Sept 2018 | - | $7.16 M(-11.0%) |
| June 2018 | - | $8.05 M(-13.1%) |
| Mar 2018 | - | $9.26 M(-9.7%) |
| Dec 2017 | $36.47 M(+31.1%) | $10.26 M(+6.2%) |
| Sept 2017 | - | $9.66 M(+14.4%) |
| June 2017 | - | $8.44 M(+4.0%) |
| Mar 2017 | - | $8.12 M(+21.6%) |
| Dec 2016 | $27.82 M(+41.5%) | $6.67 M(-7.5%) |
| Sept 2016 | - | $7.22 M(+1.8%) |
| June 2016 | - | $7.09 M(+3.6%) |
| Mar 2016 | - | $6.84 M(+23.7%) |
| Dec 2015 | $19.67 M(+13.9%) | $5.53 M(+4.8%) |
| Sept 2015 | - | $5.28 M(+17.4%) |
| June 2015 | - | $4.50 M(+2.9%) |
| Mar 2015 | - | $4.37 M(-4.2%) |
| Dec 2014 | $17.27 M(+14.4%) | $4.56 M(+14.1%) |
| Sept 2014 | - | $3.99 M(-10.4%) |
| June 2014 | - | $4.46 M(+4.7%) |
| Mar 2014 | - | $4.26 M(+4.1%) |
| Dec 2013 | $15.09 M | $4.09 M(+12.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2013 | - | $3.63 M(-2.5%) |
| June 2013 | - | $3.73 M(+2.6%) |
| Mar 2013 | - | $3.63 M(-4.7%) |
| Dec 2012 | $12.43 M(-8.5%) | $3.81 M(+27.5%) |
| Sept 2012 | - | $2.99 M(+16.5%) |
| June 2012 | - | $2.57 M(-16.0%) |
| Mar 2012 | - | $3.06 M(-111.9%) |
| Dec 2011 | $13.59 M(-4.3%) | -$25.72 M(-312.6%) |
| Sept 2011 | - | $12.10 M(-17.7%) |
| June 2011 | - | $14.70 M(+17.5%) |
| Mar 2011 | - | $12.52 M(-149.5%) |
| Dec 2010 | $14.20 M(-74.4%) | -$25.28 M(-295.1%) |
| Sept 2010 | - | $12.96 M(-4.8%) |
| June 2010 | - | $13.62 M(+5.5%) |
| Mar 2010 | - | $12.90 M(-3.9%) |
| Dec 2009 | $55.47 M(-19.6%) | $13.42 M(-2.3%) |
| Sept 2009 | - | $13.73 M(-4.1%) |
| June 2009 | - | $14.33 M(+2.5%) |
| Mar 2009 | - | $13.98 M(-2.3%) |
| Dec 2008 | $69.03 M(-1.5%) | $14.31 M(-17.5%) |
| Sept 2008 | - | $17.34 M(-9.2%) |
| June 2008 | - | $19.11 M(+4.7%) |
| Mar 2008 | - | $18.26 M(+1.1%) |
| Dec 2007 | $70.11 M(+8.8%) | $18.07 M(+4.3%) |
| Sept 2007 | - | $17.33 M(-2.3%) |
| June 2007 | - | $17.74 M(+4.5%) |
| Mar 2007 | - | $16.97 M(-1.0%) |
| Dec 2006 | $64.47 M(+20.4%) | $17.14 M(+6.4%) |
| Sept 2006 | - | $16.11 M(-1.4%) |
| June 2006 | - | $16.34 M(+9.7%) |
| Mar 2006 | - | $14.89 M(+7.6%) |
| Dec 2005 | $53.55 M(+3.2%) | $13.84 M(+10.0%) |
| Sept 2005 | - | $12.58 M(-6.4%) |
| June 2005 | - | $13.44 M(-1.7%) |
| Mar 2005 | - | $13.68 M(-5.8%) |
| Dec 2004 | $51.88 M(+20.2%) | $14.52 M(+10.8%) |
| Sept 2004 | - | $13.10 M(+5.5%) |
| June 2004 | - | $12.42 M(+5.0%) |
| Mar 2004 | - | $11.84 M(+62.4%) |
| Dec 2003 | $43.17 M(+22.0%) | - |
| June 2003 | - | $7.29 M(-6.1%) |
| Mar 2003 | - | $7.76 M |
| Dec 2002 | $35.38 M(+31.7%) | - |
| Dec 2001 | $26.86 M(+94.7%) | - |
| Dec 2000 | $13.79 M | - |
FAQ
- What is Cytokinetics Incorporated annual total operating expenses?
- What is the all time high annual operating expenses for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual operating expenses year-on-year change?
- What is Cytokinetics Incorporated quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly operating expenses year-on-year change?
What is Cytokinetics Incorporated annual total operating expenses?
The current annual operating expenses of CYTK is $173.61 M
What is the all time high annual operating expenses for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual total operating expenses is $177.98 M
What is Cytokinetics Incorporated annual operating expenses year-on-year change?
Over the past year, CYTK annual total operating expenses has changed by -$4.37 M (-2.45%)
What is Cytokinetics Incorporated quarterly total operating expenses?
The current quarterly operating expenses of CYTK is $56.65 M
What is the all time high quarterly operating expenses for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly total operating expenses is $56.65 M
What is Cytokinetics Incorporated quarterly operating expenses year-on-year change?
Over the past year, CYTK quarterly total operating expenses has changed by +$16.54 M (+41.24%)